Single-session radiosurgery for Cushing disease after failed resection: a retrospective single-center cohort study
- 10 November 2026
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
Abstract
Context: Cushing disease (CD) from an adrenocorticotropic hormone-secreting pituitary adenoma causes substantial morbidity when hypercortisolism persists or recurs after transsphenoidal surgery (TSS). Objective: To define endocrine control, radiographic response, toxicity, and predictors after single-session Gamma Knife radiosurgery for residual or recurrent CD. Design: Retrospective single-center cohort study, 1990-2026; median endocrine follow-up 54 months. Setting: Single academic tertiary referral center. Patients: 186 adults with residual or recurrent CD after ≥1 TSS and ≥12 months of follow-up. Median age 40.8 years; 78.0% female. Intervention: Single-session frame-based SRS (median prescription dose 23.0 Gy; maximum dose 48.0 Gy). Main Outcome Measures: Prespecified primary outcome was durable biochemical control off medications (sustained 24-hour urinary free cortisol [UFC] normalization without cortisol-lowering therapy), modeled with competing-risks methodology. Results: UFC normalized in 152 patients (81.7%), including 134 (72.0%) off all medications. Cumulative incidence of durable off-medication control was 51% (95% CI: 44-58%) at 12 months and 64% (95% CI: 56-71%) at 120 months. New endocrinopathy reached 42% (95% CI: 32-52%) at 120 months; new visual deficit occurred in 3.2%. A TSS-to-SRS interval <6 months independently predicted higher durable control (P < .001), while higher baseline AM cortisol (P < .001), whole-sella treatment (P = .013), and female gender (P = .027) predicted lower durable control. Higher maximum dose was the sole independent predictor of new endocrinopathy (P = .009). Conclusion: Single-session SRS achieves durable medication-free control in approximately two-thirds of patients with residual or recurrent CD, with excellent tumor control and meaningful delayed endocrine toxicity warranting long-term surveillance.This publication has 19 references indexed in Scilit:
- Radiosurgery in recurrent and persistent Cushing’s Disease: a Systematic Review and Meta-AnalysisNeurosurgical Review, 2026
- Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-AnalysisPituitary, 2025
- Consensus on diagnosis and management of Cushing's disease: a guideline updateThe Lancet Diabetes & Endocrinology, 2021
- Surgical and radiosurgical treatment strategies for Cushing’s diseaseJournal of Neuro-Oncology, 2019
- Technique of Whole-Sellar Stereotactic Radiosurgery for Cushing Disease: Results from a Multicenter, International Cohort StudyWorld Neurosurgery, 2018
- Endoscopic vs. microscopic transsphenoidal surgery for Cushing’s disease: a systematic review and meta-analysisPituitary, 2018
- Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long‐term risk of hypopituitarismClinical Endocrinology, 2015
- Long-term Evaluation of Radiation-Induced Optic Neuropathy After Single-Fraction Stereotactic RadiosurgeryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007
- A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgeryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003